India Today6h
New injection reduces risk of HIV infection by 96%: All about it
A new HIV prevention method, Lenacapavir, administered as a twice-yearly injection, has demonstrated superior results ...
Tengrinews10h
HIV vaccine passes final stage of testing
Tengrinews.kz - A revolutionary HIV drug has been created: clinical trials have shown that its twice-yearly injections are 96 ...
Medindia13h
Emory Study Finds Racial Gaps in Sudden Cardiac Arrest and Death Among Athletes
An Emory-led review highlights racial disparities in sudden cardiac arrest and death among athletes, stressing the importance ...
Black Athletes 5 Times More Likely Than White Peers To Suffer Sudden Cardiac Arrest
A new study reveals that Black athletes are five times as likely as white athletes to experience sudden cardiac arrest.
Focus Universal Inc. Announces Appointment of Professor Shivaram Rajgopal to Advisory Board
Focus Universal Inc. (NASDAQ:FCUV) (”Focus” or the “Company”), a provider of patented hardware and software design technologies for Internet of Things (IoT), 5G and SEC Financial Reporting AI-Driven ...
From chronic to curable: Twice-yearly shot shows near-total HIV eradication
Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.